Suchergebnisse - "Zenz, Thorsten"

PubPharm (21)

1

BCL3 rearrangements in B-cell lymphoid neoplasms occur in two breakpoint clusters associated with different diseases

enthalten in: Haematologica | 2024

von Carbo-Meix, A. | Guijarro, F. | Wang, L. | +42

2

SH2 domain-containing inositol 5-phosphatases support the survival of Burkitt lymphoma cells by promoting energy metabolism

enthalten in: Haematologica | 2023

von Mayr, F. | Kruse, V. | Fuhrmann, D. | +11

3

Subgroup-specific gene expression profiles and mixed epistasis in chronic lymphocytic leukemia

enthalten in: Haematologica | October, 2023

von Lütge, A. | Lu, J. | Hüllein, J. | +8

4

Subgroup-specific gene expression profiles and mixed epistasis in chronic lymphocytic leukemia

enthalten in: Haematologica | 2023

von Lütge, A. | Lu, J. | Hüllein, J. | +8

5

Clonal evolution in chronic lymphocytic leukemia is scant in relapsed but accelerated in refractory cases after chemo(immune) therapy

enthalten in: Haematologica | 2022

von Zapatka, M. | Tausch, E. | Öztürk, S. | +9

6

Genetics of "high-risk" chronic lymphocytic leukemia in the times of chemoimmunotherapy

enthalten in: Haematologica | 2020

von Ring, A. | Zenz, T.

CommentOn: Haematologica. 2020 May;105(5):1379-1390. - PMID 31467127

7

HIF-1α is over-expressed in leukemic cells from TP53-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemia

enthalten in: Haematologica | 2020

von Griggio, V. | Vitale, C. | Todaro, M. | +23

CommentIn: Haematologica. 2020 Apr;105(4):856-858. - PMID 32238465

8

Energy metabolism is co-determined by genetic variants in chronic lymphocytic leukemia and influences drug sensitivity

enthalten in: Haematologica | 2019

von Lu, J. | Böttcher, M. | Walther, T. | +3

9

Tumor necrosis factor receptor signaling is a driver of chronic lymphocytic leukemia that can be therapeutically targeted by the flavonoid wogonin

enthalten in: Haematologica | 2018

von Dürr, C. | Hanna, B. | Schulz, A. | +13

10

Tumor necrosis factor receptor signaling is a driver of chronic lymphocytic leukemia that can be therapeutically targeted by the flavonoid wogonin

enthalten in: Haematologica | January 11, 2018

von Dürr, C. | Zenz, T.